Publication: 883

A randomized phase II study of temozolomide and bevacizumab or nab-paclitaxel, carboplatin, and bevacizumab in patients with unresectable stage IV melanoma: A North Central Cancer Treatment Group Study, N0775
      QxMD      Google Scholar   
Citation:
Cancer vol 119 (3) 586-592
Year:
2013
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pmc-release
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
2
Parents:
580  
Children:
None
Program:
OGC
Primary Committee:
Experimental
Sec. Committees:
   
Pharmas:
 
Grants:
 
Corr. Author:
 
Authors:
                         
Networks:
 
Study
NCCTG-N0775
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2
Keywords:
metastatic melanoma, chemotherapy, VEGF inhibition, combination therapy, unresectable metastatic melanoma